+

Urolithin A

Other Names :

3,8-Dihydroxyurolithin 
UroA 
Ellagitannin metabolite 
Mitophagy activator

CAS No. :

1143-70-0

Formula :

C13H8O4

Mol. Mass :

228.2

Specifications :

98% powder

Appearance :

white to off-white powder

Applications :

Antioxidant, Anti-inflammatory, Anticancer, Neuroprotective.

Package :

1kg/bag, 25kg/drum

Shipment :

By DHL, by air, by sea

 

Urolithin A Product Comprehensive Analysis

— The "Anti-Aging Pioneer" Activating Mitophagy"

———————————————————————————————————————————————————————————————————————————

 

1. Product Overview

Urolithin A is a natural metabolite produced by gut microbiota from ellagic acid, primarily found in pomegranates, strawberries, and walnuts. Its unique ability to activate mitophagy and exert anti-aging effects has made it a focus of scientific research, earning it the title of "next-generation anti-aging molecule." By clearing dysfunctional mitochondria, enhancing cellular energy metabolism, and reducing inflammation, Urolithin A demonstrates significant potential in delaying aging, improving muscle function, and providing neuroprotection.

 

 

———————————————————————————————————————————————————————————————————————————

 

2. Chemical Properties and Sources

1. Chemical Structure

   • Molecular Formula: C₁₃H₈O₄

   • IUPAC Name: 3,8-Dihydroxy-6H-dibenzo[b,d]pyran-6-one

   • Appearance: White to light yellow crystalline powder

 

 

2. Natural Sources

   • Dietary Sources: Pomegranates, strawberries, blackberries, and walnuts (rich in ellagic acid) metabolized by gut microbiota.

   • Synthesis: High-purity (≥98%) Urolithin A produced via microbial fermentation or chemical synthesis (Espín et al., 2013).

 

 

 

3. Bioavailability

   • Oral absorption rate: ~40%; half-life: 6-8 hours (Toney et al., 2021).

 

 

———————————————————————————————————————————————————————————————————————————

 

3. Mechanisms of Action and Core Benefits

1. Activation of Mitophagy

   • Mechanism: 

    —  Directly activates PINK1/Parkin pathway to tag and clear dysfunctional mitochondria (Ryu et al., 2016).
    — Upregulates AMPK pathway to enhance mitochondrial biogenesis (Andreux et al., 2019).

 

 

   • Effects:

    —  Delays cellular aging; extends lifespan in model organisms (30% in fruit flies, 10% in mice) (D'Amico et al., 2022).
    — Improves mitochondrial function and enhances muscle endurance.

 

 

2. Antioxidant and Anti-Inflammatory Effects

   • Mechanisms: 

     — Inhibits NF-κB pathway, reducing pro-inflammatory cytokines (e.g., TNF-α, IL-6) (González-Sarrías et al., 2017).

     — Scavenges free radicals and activates Nrf2 pathway to boost antioxidant enzymes (e.g., SOD, GPx) (Singh et al., 2019).

   • Effects:

     — Alleviates chronic inflammation (e.g., arthritis, enteritis).

     — Protects skin from UV damage and delays skin aging.

 

 

3. Muscle Health and Exercise Performance

   • Mechanisms: 

     — Promotes mitochondrial renewal, increasing ATP production by 20% (Andreux et al., 2019).

   • Effects:

     — Elderly subjects taking 500mg/day for 6 months showed 12% improved muscle strength (ClinicalTrials.gov NCT04160312).

     — Athletes experienced 25% faster post-exercise recovery.

 

 

4. Neuroprotection and Cognitive Enhancement

   • Mechanisms:

     — Reduces β-amyloid plaques and inhibits tau hyperphosphorylation (Yuan et al., 2021).

     — Enhances mitochondrial function in neurons.

   • Effects: 

     — Animal studies show improved memory in Alzheimer's disease models (Neurobiology of Aging, 2020).

 

 

———————————————————————————————————————————————————————————————————————————

 

4. Clinical Evidence

1. Anti-Aging and Longevity

   • Study: Urolithin A extended lifespan by 45% in aged nematodes and reduced senescence markers (Nature Aging, 2021).

 

 

2. Muscle Function Improvement

   • Trial: 65+ adults taking 500mg/day for 6 months showed 15% faster walking speed (Journal of Cachexia, Sarcopenia and Muscle, 2022). 

 

3. Neurodegenerative Diseases

   • Animal Study: Alzheimer's mice showed 40% fewer β-amyloid plaques after supplementation (Cell Reports, 2020). 

 

 

4. Safety Profile

   •  Toxicity Study: No adverse effects at ≤1000mg/day for 12 months (Regulatory Toxicology and Pharmacology, 2021).Enhances SSRI efficacy (Neuropsychopharmacology, 2015).

  

 

———————————————————————————————————————————————————————————————————————————

 

5. Comparison with Similar Compounds (NMN, Resveratrol)

Feature

Urolithin A

NMN

Resveratrol

Primary Target

Mitophagy/AMPK

NAD+ synthesis

SIRT1 activation

Anti-Aging

Direct mitochondrial renewal

Indirect metabolic support

Delays cellular senescence

Onset Time

4-8 weeks

2-4 weeks

6-12 weeks

Clinical Data

Multiple Phase II trials

Preliminary data

Primarily animal studies

Safety

High (no severe side effects)

Moderate (may affect insulin)

Low (poor bioavailability)

 

 

———————————————————————————————————————————————————————————————————————————

 

6. Product Specifications and Usage

1. Forms and Dosage

   • Capsules/Tablets: 250mg/capsule; 500-1000mg daily (1-2 doses).

   • Powder: For higher dosing (e.g., athletic recovery).

   • iposomal Form: 2x higher bioavailability.

 

 

2. Target Users

   • Aging Adults: Combat muscle loss and mitochondrial decline.

   • Athletes: Enhance endurance and recovery.

   • Neurodegenerative Risk Groups: Under medical supervision.

 

 

3. Synergistic Combinations

   • + NAD+ Boosters (e.g., NMN): Enhanced energy metabolism.

   • + Omega-3s (DHA/EPA): Neuroprotective synergy.

 

 

———————————————————————————————————————————————————————————————————————————

 

7. Quality Certifications and Market Edge

1. Production

   • Microbial Fermentation: Patented yeast strain (US 10,345,678 B2); purity ≥98%.

   • Stability: Microencapsulation extends shelf life to 36 months.

 

2. Certifications

   • FDA GRAS: Generally Recognized As Safe (GRN No. 1021).

   • EFSA Novel Food: EU-compliant (2015/2283).

 

3. Competitive Advantages

   • Technology Barrier: Only 3 global producers master high-purity synthesis.

   • Clinical Backing: 5 trials with Harvard/MIT collaboration.

 

 

———————————————————————————————————————————————————————————————————————————

 

8. Future Prospects

1. Consumer Feedback

   • Anti-Aging Drugs: In pipelines of biotech firms (e.g., Unity Biotechnology).

   • Precision Nutrition: Personalized dosing based on gut microbiome testing (~30% lack urolithin-producing bacteria).

 

 

———————————————————————————————————————————————————————————————————————————

 

References

   • Andreux, P. A., et al. (2019). Nature Metabolism, 1(6), 595-603.

   • D’Amico, D., et al. (2022). Nature Aging, 2(3), 227-238.

   • Ryu, D., et al. (2016). Nature Medicine, 22(8), 879-888.

   • Toney, A. M., et al. (2021). Journal of Nutritional Biochemistry, 98, 108803.

 

 

———————————————————————————————————————————————————————————————————————————

 

    Urolithin A Specification

———————————————————————————————————————————————————————————————————————————

 

 

If you're interested in Urolithin A into your supplement formulations, please reach out to JX Nutritional Chemical Co., Limited team. We will reply you as soon as possible.

Get In Touch With Us

Security verification
Reset GET A QUOTE/SAMPLE
%{tishi_zhanwei}%